1 Introduction to Research & Analysis Reports
    1.1 Plasma-derived Factor VIII Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Plasma-derived Factor VIII Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Plasma-derived Factor VIII Overall Market Size
    2.1 Global Plasma-derived Factor VIII Market Size: 2021 VS 2027
    2.2 Global Plasma-derived Factor VIII Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Plasma-derived Factor VIII Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Plasma-derived Factor VIII Players in Global Market
    3.2 Top Global Plasma-derived Factor VIII Companies Ranked by Revenue
    3.3 Global Plasma-derived Factor VIII Revenue by Companies
    3.4 Global Plasma-derived Factor VIII Sales by Companies
    3.5 Global Plasma-derived Factor VIII Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Plasma-derived Factor VIII Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Plasma-derived Factor VIII Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Plasma-derived Factor VIII Players in Global Market
        3.8.1 List of Global Tier 1 Plasma-derived Factor VIII Companies
        3.8.2 List of Global Tier 2 and Tier 3 Plasma-derived Factor VIII Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Plasma-derived Factor VIII Market Size Markets, 2021 & 2027
        4.1.2 200IU
        4.1.3 250IU
    4.2 By Type - Global Plasma-derived Factor VIII Revenue & Forecasts
        4.2.1 By Type - Global Plasma-derived Factor VIII Revenue, 2016-2021
        4.2.2 By Type - Global Plasma-derived Factor VIII Revenue, 2022-2027
        4.2.3 By Type - Global Plasma-derived Factor VIII Revenue Market Share, 2016-2027
    4.3 By Type - Global Plasma-derived Factor VIII Sales & Forecasts
        4.3.1 By Type - Global Plasma-derived Factor VIII Sales, 2016-2021
        4.3.2 By Type - Global Plasma-derived Factor VIII Sales, 2022-2027
        4.3.3 By Type - Global Plasma-derived Factor VIII Sales Market Share, 2016-2027
    4.4 By Type - Global Plasma-derived Factor VIII Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Plasma-derived Factor VIII Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Pharmacy
    5.2 By Application - Global Plasma-derived Factor VIII Revenue & Forecasts
        5.2.1 By Application - Global Plasma-derived Factor VIII Revenue, 2016-2021
        5.2.2 By Application - Global Plasma-derived Factor VIII Revenue, 2022-2027
        5.2.3 By Application - Global Plasma-derived Factor VIII Revenue Market Share, 2016-2027
    5.3 By Application - Global Plasma-derived Factor VIII Sales & Forecasts
        5.3.1 By Application - Global Plasma-derived Factor VIII Sales, 2016-2021
        5.3.2 By Application - Global Plasma-derived Factor VIII Sales, 2022-2027
        5.3.3 By Application - Global Plasma-derived Factor VIII Sales Market Share, 2016-2027
    5.4 By Application - Global Plasma-derived Factor VIII Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Plasma-derived Factor VIII Market Size, 2021 & 2027
    6.2 By Region - Global Plasma-derived Factor VIII Revenue & Forecasts
        6.2.1 By Region - Global Plasma-derived Factor VIII Revenue, 2016-2021
        6.2.2 By Region - Global Plasma-derived Factor VIII Revenue, 2022-2027
        6.2.3 By Region - Global Plasma-derived Factor VIII Revenue Market Share, 2016-2027
    6.3 By Region - Global Plasma-derived Factor VIII Sales & Forecasts
        6.3.1 By Region - Global Plasma-derived Factor VIII Sales, 2016-2021
        6.3.2 By Region - Global Plasma-derived Factor VIII Sales, 2022-2027
        6.3.3 By Region - Global Plasma-derived Factor VIII Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Plasma-derived Factor VIII Revenue, 2016-2027
        6.4.2 By Country - North America Plasma-derived Factor VIII Sales, 2016-2027
        6.4.3 US Plasma-derived Factor VIII Market Size, 2016-2027
        6.4.4 Canada Plasma-derived Factor VIII Market Size, 2016-2027
        6.4.5 Mexico Plasma-derived Factor VIII Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Plasma-derived Factor VIII Revenue, 2016-2027
        6.5.2 By Country - Europe Plasma-derived Factor VIII Sales, 2016-2027
        6.5.3 Germany Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.4 France Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.5 U.K. Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.6 Italy Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.7 Russia Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.8 Nordic Countries Plasma-derived Factor VIII Market Size, 2016-2027
        6.5.9 Benelux Plasma-derived Factor VIII Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Plasma-derived Factor VIII Revenue, 2016-2027
        6.6.2 By Region - Asia Plasma-derived Factor VIII Sales, 2016-2027
        6.6.3 China Plasma-derived Factor VIII Market Size, 2016-2027
        6.6.4 Japan Plasma-derived Factor VIII Market Size, 2016-2027
        6.6.5 South Korea Plasma-derived Factor VIII Market Size, 2016-2027
        6.6.6 Southeast Asia Plasma-derived Factor VIII Market Size, 2016-2027
        6.6.7 India Plasma-derived Factor VIII Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Plasma-derived Factor VIII Revenue, 2016-2027
        6.7.2 By Country - South America Plasma-derived Factor VIII Sales, 2016-2027
        6.7.3 Brazil Plasma-derived Factor VIII Market Size, 2016-2027
        6.7.4 Argentina Plasma-derived Factor VIII Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Plasma-derived Factor VIII Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Plasma-derived Factor VIII Sales, 2016-2027
        6.8.3 Turkey Plasma-derived Factor VIII Market Size, 2016-2027
        6.8.4 Israel Plasma-derived Factor VIII Market Size, 2016-2027
        6.8.5 Saudi Arabia Plasma-derived Factor VIII Market Size, 2016-2027
        6.8.6 UAE Plasma-derived Factor VIII Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Takeda
        7.1.1 Takeda Corporate Summary
        7.1.2 Takeda Business Overview
        7.1.3 Takeda Plasma-derived Factor VIII Major Product Offerings
        7.1.4 Takeda Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.1.5 Takeda Key News
    7.2 Octapharma
        7.2.1 Octapharma Corporate Summary
        7.2.2 Octapharma Business Overview
        7.2.3 Octapharma Plasma-derived Factor VIII Major Product Offerings
        7.2.4 Octapharma Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.2.5 Octapharma Key News
    7.3 CSL
        7.3.1 CSL Corporate Summary
        7.3.2 CSL Business Overview
        7.3.3 CSL Plasma-derived Factor VIII Major Product Offerings
        7.3.4 CSL Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.3.5 CSL Key News
    7.4 Grifols
        7.4.1 Grifols Corporate Summary
        7.4.2 Grifols Business Overview
        7.4.3 Grifols Plasma-derived Factor VIII Major Product Offerings
        7.4.4 Grifols Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.4.5 Grifols Key News
    7.5 Greencross
        7.5.1 Greencross Corporate Summary
        7.5.2 Greencross Business Overview
        7.5.3 Greencross Plasma-derived Factor VIII Major Product Offerings
        7.5.4 Greencross Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.5.5 Greencross Key News
    7.6 Kedrion
        7.6.1 Kedrion Corporate Summary
        7.6.2 Kedrion Business Overview
        7.6.3 Kedrion Plasma-derived Factor VIII Major Product Offerings
        7.6.4 Kedrion Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.6.5 Kedrion Key News
    7.7 BPL
        7.7.1 BPL Corporate Summary
        7.7.2 BPL Business Overview
        7.7.3 BPL Plasma-derived Factor VIII Major Product Offerings
        7.4.4 BPL Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.7.5 BPL Key News
    7.8 Hualan Bio
        7.8.1 Hualan Bio Corporate Summary
        7.8.2 Hualan Bio Business Overview
        7.8.3 Hualan Bio Plasma-derived Factor VIII Major Product Offerings
        7.8.4 Hualan Bio Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.8.5 Hualan Bio Key News
    7.9 RAAS
        7.9.1 RAAS Corporate Summary
        7.9.2 RAAS Business Overview
        7.9.3 RAAS Plasma-derived Factor VIII Major Product Offerings
        7.9.4 RAAS Plasma-derived Factor VIII Sales and Revenue in Global (2016-2021)
        7.9.5 RAAS Key News
8 Global Plasma-derived Factor VIII Production Capacity, Analysis
    8.1 Global Plasma-derived Factor VIII Production Capacity, 2016-2027
    8.2 Plasma-derived Factor VIII Production Capacity of Key Manufacturers in Global Market
    8.3 Global Plasma-derived Factor VIII Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Plasma-derived Factor VIII Supply Chain Analysis
    10.1 Plasma-derived Factor VIII Industry Value Chain
    10.2 Plasma-derived Factor VIII Upstream Market
    10.3 Plasma-derived Factor VIII Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Plasma-derived Factor VIII Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer